Related Experiment Video
Updated: Oct 3, 2025

Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
Published on: December 23, 2022
Predominant Single Stable VpmaV Expression in Strain GM139 and Major Differences with Mycoplasma agalactiae Type
Maysa Santos Barbosa1,2, Joachim Spergser1, Lucas Miranda Marques2,3
1Institute of Microbiology, Department of Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria.
Abstract:
Although mycoplasmas have a reduced genome and no cell wall, they have important mechanisms for the antigenic variation in surface lipoproteins that modulate their interactions with the host. Mycoplasma agalactiae, the main etiological agent of contagious agalactia, has a multigene family involved in the high-frequency phase variation in surface lipoproteins called variable proteins of M. agalactiae (Vpmas). The Vpma lipoproteins are involved in the immune evasion, colonization, dissemination, and persistence of M. agalactiae in the host. In this paper, we evaluate the Vpma phenotypic profiles of two different strains of M. agalactiae, namely, GM139 and the type strain PG2, to assess possible correlations between Vpma phase variability and the geographic localization, animal origin, and pathogenicity of these two strains. Using monospecific Vpma antibodies against individual Vpmas in immunoblots, we demonstrate that, unlike PG2, which expresses six Vpma proteins with high-frequency phase variation, colonies of GM139 predominantly express VpmaV and do not exhibit any sectoring phenotype for any Vpma. Since VpmaV is one of the most important Vpmas for cell adhesion and invasion, its predominant sole expression in GM139 without high-frequency variation may be the basis of the differential pathogenicity of GM139 and PG2. Additionally, MALDI-ToF MS analysis also demonstrates significant differences between these two strains and their relatedness with other M. agalactiae strains.
Insights
Mycoplasma agalactiae uses variable surface lipoproteins (Vpmas) for immune evasion. Strain GM139
Area of Science:
- Microbiology
- Immunology
- Bacteriology
Background:
- Mycoplasmas, including Mycoplasma agalactiae, possess mechanisms for antigenic variation in surface lipoproteins.
- Variable proteins of M. agalactiae (Vpmas) are lipoproteins involved in immune evasion, colonization, dissemination, and persistence.
- Vpmas undergo high-frequency phase variation, modulating host interactions.
Purpose of the Study:
- To evaluate Vpma phenotypic profiles of Mycoplasma agalactiae strains GM139 and PG2.
- To assess correlations between Vpma phase variability and strain pathogenicity, geographic origin, and animal source.
- To understand the role of Vpma expression in differential pathogenicity.
Main Methods:
- Immunoblot analysis using monospecific Vpma antibodies.
- Phenotypic characterization of Vpma expression in different strains.
- MALDI-ToF MS analysis for strain relatedness.
Main Results:
- Mycoplasma agalactiae strain PG2 expresses six Vpma proteins with high-frequency phase variation.
- Strain GM139 predominantly expresses VpmaV and lacks high-frequency Vpma phase variation.
- MALDI-ToF MS revealed significant differences between GM139, PG2, and other M. agalactiae strains.
Conclusions:
- Predominant expression of VpmaV without high-frequency variation in GM139 may explain its differential pathogenicity compared to PG2.
- Vpma phase variation significantly impacts Mycoplasma agalactiae virulence and host interaction.
- Distinct Vpma profiles contribute to the genetic diversity and pathogenicity of M. agalactiae strains.
More Related Videos
08:57Identification of Novel Genes Associated with Alginate Production in Pseudomonas aeruginosa Using Mini-himar1 Mariner Transposon-mediated Mutagenesis
Published on: March 10, 2014
12:16Porphyromonas gingivalis as a Model Organism for Assessing Interaction of Anaerobic Bacteria with Host Cells
Published on: December 17, 2015